Recent developments in antitubercular drugs.
This review article describes the current TB drugs, their merits and demerits as well as the new promising anti-TB agents such as diarylquinolines, oxazolidinones and nitroimdiazoles. It also includes the future development of new antitubercular agents according to the potential drug targets of Mycobacterium tuberculosis and structure-activity relationship studies on important anti-TB drugs.
Ahirrao
Pallavi
P
Type V/11, NIPER Campus, Sector-67, SAS Nagar (Mohali)- 160062, Punjab, India. pahirrao11@gmail.com
D000818:Animals; D000995:Antitubercular Agents / Q000737:chemistry / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests; D015394:Molecular Structure; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000201:enzymology; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D000995:Antitubercular Agents; D004791:Enzyme Inhibitors